|  Help  |  About  |  Contact Us

Search our database by keyword

- or -

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 101 to 200 out of 251 for Ido1

Category restricted to Publication (x)

0.045s

Categories

Category: Publication
Type Details Score
Publication
First Author: Munn DH
Year: 1998
Journal: Science
Title: Prevention of allogeneic fetal rejection by tryptophan catabolism.
Volume: 281
Issue: 5380
Pages: 1191-3
Publication
First Author: Hayashi T
Year: 2001
Journal: Infect Immun
Title: Enhancement of innate immunity against Mycobacterium avium infection by immunostimulatory DNA is mediated by indoleamine 2,3-dioxygenase.
Volume: 69
Issue: 10
Pages: 6156-64
Publication
First Author: Mellor A
Year: 2005
Journal: Biochem Biophys Res Commun
Title: Indoleamine 2,3 dioxygenase and regulation of T cell immunity.
Volume: 338
Issue: 1
Pages: 20-4
Publication
First Author: Zheng X
Year: 2006
Journal: J Immunol
Title: Reinstalling antitumor immunity by inhibiting tumor-derived immunosuppressive molecule IDO through RNA interference.
Volume: 177
Issue: 8
Pages: 5639-46
Publication
First Author: Jalili RB
Year: 2009
Journal: Am J Pathol
Title: Mouse pancreatic islets are resistant to indoleamine 2,3 dioxygenase-induced general control nonderepressible-2 kinase stress pathway and maintain normal viability and function.
Volume: 174
Issue: 1
Pages: 196-205
Publication
First Author: van der Marel AP
Year: 2007
Journal: J Immunol
Title: Blockade of IDO inhibits nasal tolerance induction.
Volume: 179
Issue: 2
Pages: 894-900
Publication
First Author: Schafer CC
Year: 2016
Journal: Oncotarget
Title: Indoleamine 2,3-dioxygenase regulates anti-tumor immunity in lung cancer by metabolic reprogramming of immune cells in the tumor microenvironment.
Volume: 7
Issue: 46
Pages: 75407-75424
Publication
First Author: Habara-Ohkubo A
Year: 1991
Journal: Gene
Title: Cloning and expression of a cDNA encoding mouse indoleamine 2,3-dioxygenase.
Volume: 105
Issue: 2
Pages: 221-7
Publication
First Author: Metz R
Year: 2007
Journal: Cancer Res
Title: Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan.
Volume: 67
Issue: 15
Pages: 7082-7
Publication
First Author: Laurans L
Year: 2018
Journal: Nat Med
Title: Genetic deficiency of indoleamine 2,3-dioxygenase promotes gut microbiota-mediated metabolic health.
Volume: 24
Issue: 8
Pages: 1113-1120
Publication
First Author: Mellor AL
Year: 2004
Journal: Int Immunol
Title: Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase.
Volume: 16
Issue: 10
Pages: 1391-401
Publication
First Author: Muller AJ
Year: 2005
Journal: Nat Med
Title: Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy.
Volume: 11
Issue: 3
Pages: 312-9
Publication  
First Author: Heisler JM
Year: 2015
Journal: Brain Behav Immun
Title: Indoleamine 2,3-dioxygenase-dependent neurotoxic kynurenine metabolism mediates inflammation-induced deficit in recognition memory.
Volume: 50
Pages: 115-124
Publication  
First Author: Lanz TV
Year: 2017
Journal: Sci Rep
Title: Tryptophan-2,3-Dioxygenase (TDO) deficiency is associated with subclinical neuroprotection in a mouse model of multiple sclerosis.
Volume: 7
Pages: 41271
Publication  
First Author: Maganin AG
Year: 2022
Journal: J Clin Invest
Title: Meningeal dendritic cells drive neuropathic pain through elevation of the kynurenine metabolic pathway in mice.
Volume: 132
Issue: 23
Publication  
First Author: Kanai M
Year: 2009
Journal: Mol Brain
Title: Tryptophan 2,3-dioxygenase is a key modulator of physiological neurogenesis and anxiety-related behavior in mice.
Volume: 2
Pages: 8
Publication
First Author: Larkin PB
Year: 2016
Journal: Biochim Biophys Acta
Title: Tryptophan 2,3-dioxygenase and indoleamine 2,3-dioxygenase 1 make separate, tissue-specific contributions to basal and inflammation-induced kynurenine pathway metabolism in mice.
Volume: 1860
Issue: 11 Pt A
Pages: 2345-2354
Publication
First Author: Minhas PS
Year: 2019
Journal: Nat Immunol
Title: Macrophage de novo NAD+ synthesis specifies immune function in aging and inflammation.
Volume: 20
Issue: 1
Pages: 50-63
Publication
First Author: Yamamoto Y
Year: 2018
Journal: Sci Rep
Title: Lipopolysaccharide shock reveals the immune function of indoleamine 2,3-dioxygenase 2 through the regulation of IL-6/stat3 signalling.
Volume: 8
Issue: 1
Pages: 15917
Publication  
First Author: Fujii K
Year: 2020
Journal: Int J Mol Sci
Title: Indoleamine 2,3-Dioxygenase 2 Deficiency Exacerbates Imiquimod-Induced Psoriasis-Like Skin Inflammation.
Volume: 21
Issue: 15
Publication
First Author: Baban B
Year: 2005
Journal: Int Immunol
Title: A minor population of splenic dendritic cells expressing CD19 mediates IDO-dependent T cell suppression via type I IFN signaling following B7 ligation.
Volume: 17
Issue: 7
Pages: 909-19
Publication  
First Author: Tran HQ
Year: 2020
Journal: Food Chem Toxicol
Title: Indoleamine-2,3-dioxygenase-1 is a molecular target for the protective activity of mood stabilizers against mania-like behavior induced by d-amphetamine.
Volume: 136
Pages: 110986
Publication
First Author: Noh KT
Year: 2017
Journal: J Biol Chem
Title: Platelet-activating Factor Mediates Endotoxin Tolerance by Regulating Indoleamine 2,3-Dioxygenase-dependent Expression of the Suppressor of Cytokine Signaling 3.
Volume: 292
Issue: 8
Pages: 3290-3298
Publication
First Author: Ito H
Year: 2010
Journal: J Immunol
Title: Ability of IDO to attenuate liver injury in alpha-galactosylceramide-induced hepatitis model.
Volume: 185
Issue: 8
Pages: 4554-60
Publication
First Author: Riella LV
Year: 2013
Journal: Am J Pathol
Title: B7h (ICOS-L) maintains tolerance at the fetomaternal interface.
Volume: 182
Issue: 6
Pages: 2204-13
Publication
First Author: Van de Velde LA
Year: 2016
Journal: Cell Metab
Title: Issues with the Specificity of Immunological Reagents for Murine IDO1.
Volume: 23
Issue: 3
Pages: 389-90
Publication
First Author: Spranger S
Year: 2013
Journal: Sci Transl Med
Title: Up-regulation of PD-L1, IDO, and T(regs) in the melanoma tumor microenvironment is driven by CD8(+) T cells.
Volume: 5
Issue: 200
Pages: 200ra116
Publication
First Author: Chang MY
Year: 2011
Journal: Cancer Biol Ther
Title: Cardiac and gastrointestinal liabilities caused by deficiency in the immune modulatory enzyme indoleamine 2,3-dioxygenase.
Volume: 12
Issue: 12
Pages: 1050-8
Publication
First Author: Munn DH
Year: 2005
Journal: Immunity
Title: GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase.
Volume: 22
Issue: 5
Pages: 633-42
Publication
First Author: Manlapat AK
Year: 2007
Journal: Eur J Immunol
Title: Cell-autonomous control of interferon type I expression by indoleamine 2,3-dioxygenase in regulatory CD19+ dendritic cells.
Volume: 37
Issue: 4
Pages: 1064-71
Publication
First Author: Sharma MD
Year: 2007
Journal: J Clin Invest
Title: Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase.
Volume: 117
Issue: 9
Pages: 2570-82
Publication
First Author: Mellor AL
Year: 2005
Journal: J Immunol
Title: Cutting edge: CpG oligonucleotides induce splenic CD19+ dendritic cells to acquire potent indoleamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN Type 1 signaling.
Volume: 175
Issue: 9
Pages: 5601-5
Publication
First Author: Lemos H
Year: 2016
Journal: Cancer Res
Title: STING Promotes the Growth of Tumors Characterized by Low Antigenicity via IDO Activation.
Volume: 76
Issue: 8
Pages: 2076-81
Publication
First Author: Metghalchi S
Year: 2018
Journal: PLoS One
Title: Indoleamine 2 3-dioxygenase knockout limits angiotensin II-induced aneurysm in low density lipoprotein receptor-deficient mice fed with high fat diet.
Volume: 13
Issue: 3
Pages: e0193737
Publication
First Author: Clement CC
Year: 2021
Journal: Nat Commun
Title: 3-hydroxy-L-kynurenamine is an immunomodulatory biogenic amine.
Volume: 12
Issue: 1
Pages: 4447
Publication
First Author: Melhem NJ
Year: 2021
Journal: Circulation
Title: Endothelial Cell Indoleamine 2, 3-Dioxygenase 1 Alters Cardiac Function After Myocardial Infarction Through Kynurenine.
Volume: 143
Issue: 6
Pages: 566-580
Publication
First Author: Stanley CP
Year: 2019
Journal: Nature
Title: Singlet molecular oxygen regulates vascular tone and blood pressure in inflammation.
Volume: 566
Issue: 7745
Pages: 548-552
Publication    
First Author: Lissner MM
Year: 2020
Journal: Elife
Title: Metabolic profiling during malaria reveals the role of the aryl hydrocarbon receptor in regulating kidney injury.
Volume: 9
Publication
First Author: Wang Q
Year: 2017
Journal: Circulation
Title: Tryptophan-Derived 3-Hydroxyanthranilic Acid Contributes to Angiotensin II-Induced Abdominal Aortic Aneurysm Formation in Mice In Vivo.
Volume: 136
Issue: 23
Pages: 2271-2283
Publication
First Author: Cole JE
Year: 2015
Journal: Proc Natl Acad Sci U S A
Title: Indoleamine 2,3-dioxygenase-1 is protective in atherosclerosis and its metabolites provide new opportunities for drug development.
Volume: 112
Issue: 42
Pages: 13033-8
Publication  
First Author: Tanaka Y
Year: 2021
Journal: Int J Mol Sci
Title: Increased Indoleamine 2,3-Dioxygenase Levels at the Onset of Sjögren's Syndrome in SATB1-Conditional Knockout Mice.
Volume: 22
Issue: 18
Publication
First Author: Wang Y
Year: 2010
Journal: Nat Med
Title: Kynurenine is an endothelium-derived relaxing factor produced during inflammation.
Volume: 16
Issue: 3
Pages: 279-85
Publication
First Author: Ohtaki H
Year: 2014
Journal: Biochim Biophys Acta
Title: Kynurenine production mediated by indoleamine 2,3-dioxygenase aggravates liver injury in HBV-specific CTL-induced fulminant hepatitis.
Volume: 1842
Issue: 9
Pages: 1464-71
Publication
First Author: Mezrich JD
Year: 2010
Journal: J Immunol
Title: An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells.
Volume: 185
Issue: 6
Pages: 3190-8
Publication
First Author: Muller AJ
Year: 2010
Journal: Cancer Res
Title: Immunotherapeutic suppression of indoleamine 2,3-dioxygenase and tumor growth with ethyl pyruvate.
Volume: 70
Issue: 5
Pages: 1845-53
Publication
First Author: Tawara I
Year: 2010
Journal: J Immunol
Title: A crucial role for host APCs in the induction of donor CD4+CD25+ regulatory T cell-mediated suppression of experimental graft-versus-host disease.
Volume: 185
Issue: 7
Pages: 3866-72
Publication
First Author: Ito H
Year: 2015
Journal: Immunology
Title: Inhibition of indoleamine 2,3-dioxygenase activity enhances the anti-tumour effects of a Toll-like receptor 7 agonist in an established cancer model.
Volume: 144
Issue: 4
Pages: 621-30
Publication
First Author: Belladonna ML
Year: 2006
Journal: J Immunol
Title: Kynurenine pathway enzymes in dendritic cells initiate tolerogenesis in the absence of functional IDO.
Volume: 177
Issue: 1
Pages: 130-7
Publication
First Author: Ueno A
Year: 2007
Journal: Diabetes
Title: Transient upregulation of indoleamine 2,3-dioxygenase in dendritic cells by human chorionic gonadotropin downregulates autoimmune diabetes.
Volume: 56
Issue: 6
Pages: 1686-93
Publication  
First Author: Baumann KK
Year: 2023
Journal: Int J Mol Sci
Title: Effects of Ozone on Sickness and Depressive-like Behavioral and Biochemical Phenotypes and Their Regulation by Serum Amyloid A in Mice.
Volume: 24
Issue: 2
Publication
First Author: Cobbold SP
Year: 2009
Journal: Proc Natl Acad Sci U S A
Title: Infectious tolerance via the consumption of essential amino acids and mTOR signaling.
Volume: 106
Issue: 29
Pages: 12055-60
Publication
First Author: Ravishankar B
Year: 2012
Journal: Proc Natl Acad Sci U S A
Title: Tolerance to apoptotic cells is regulated by indoleamine 2,3-dioxygenase.
Volume: 109
Issue: 10
Pages: 3909-14
Publication
First Author: Lee J
Year: 2013
Journal: PLoS One
Title: Interferon gamma suppresses collagen-induced arthritis by regulation of Th17 through the induction of indoleamine-2,3-deoxygenase.
Volume: 8
Issue: 4
Pages: e60900
Publication
First Author: Lu Y
Year: 2012
Journal: Blood
Title: IFN-γ and indoleamine 2,3-dioxygenase signaling between donor dendritic cells and T cells regulates graft versus host and graft versus leukemia activity.
Volume: 119
Issue: 4
Pages: 1075-85
Publication
First Author: Fallarino F
Year: 2009
Journal: J Immunol
Title: IDO mediates TLR9-driven protection from experimental autoimmune diabetes.
Volume: 183
Issue: 10
Pages: 6303-12
Publication
First Author: Johnson BA 3rd
Year: 2010
Journal: Proc Natl Acad Sci U S A
Title: B-lymphoid cells with attributes of dendritic cells regulate T cells via indoleamine 2,3-dioxygenase.
Volume: 107
Issue: 23
Pages: 10644-8
Publication
First Author: Sumpter TL
Year: 2012
Journal: J Immunol
Title: Hepatic stellate cells undermine the allostimulatory function of liver myeloid dendritic cells via STAT3-dependent induction of IDO.
Volume: 189
Issue: 8
Pages: 3848-58
Publication
First Author: Wang Q
Year: 2014
Journal: Circ Res
Title: Activation of NAD(P)H oxidase by tryptophan-derived 3-hydroxykynurenine accelerates endothelial apoptosis and dysfunction in vivo.
Volume: 114
Issue: 3
Pages: 480-92
Publication
First Author: Loughman JA
Year: 2012
Journal: J Infect Dis
Title: Induction of indoleamine 2,3-dioxygenase by uropathogenic bacteria attenuates innate responses to epithelial infection.
Volume: 205
Issue: 12
Pages: 1830-9
Publication
First Author: Orabona C
Year: 2006
Journal: Blood
Title: Toward the identification of a tolerogenic signature in IDO-competent dendritic cells.
Volume: 107
Issue: 7
Pages: 2846-54
Publication
First Author: De Luca A
Year: 2007
Journal: J Immunol
Title: Functional yet balanced reactivity to Candida albicans requires TRIF, MyD88, and IDO-dependent inhibition of Rorc.
Volume: 179
Issue: 9
Pages: 5999-6008
Publication
First Author: Qu J
Year: 2019
Journal: Int J Cancer
Title: CARD9 prevents lung cancer development by suppressing the expansion of myeloid-derived suppressor cells and IDO production.
Volume: 145
Issue: 8
Pages: 2225-2237
Publication
First Author: Shinde R
Year: 2018
Journal: Nat Immunol
Title: Apoptotic cell-induced AhR activity is required for immunological tolerance and suppression of systemic lupus erythematosus in mice and humans.
Volume: 19
Issue: 6
Pages: 571-582
Publication
First Author: Baban B
Year: 2011
Journal: J Immunol
Title: Physiologic control of IDO competence in splenic dendritic cells.
Volume: 187
Issue: 5
Pages: 2329-35
Publication
First Author: Sharma MD
Year: 2009
Journal: Blood
Title: Indoleamine 2,3-dioxygenase controls conversion of Foxp3+ Tregs to TH17-like cells in tumor-draining lymph nodes.
Volume: 113
Issue: 24
Pages: 6102-11
Publication
First Author: Vinay DS
Year: 2009
Journal: Eur J Immunol
Title: Origins and functional basis of regulatory CD11c+CD8+ T cells.
Volume: 39
Issue: 6
Pages: 1552-63
Publication
First Author: Jasperson LK
Year: 2009
Journal: Blood
Title: Inducing the tryptophan catabolic pathway, indoleamine 2,3-dioxygenase (IDO), for suppression of graft-versus-host disease (GVHD) lethality.
Volume: 114
Issue: 24
Pages: 5062-70
Publication
First Author: Zelante T
Year: 2013
Journal: Immunity
Title: Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22.
Volume: 39
Issue: 2
Pages: 372-85
Publication
First Author: Desvignes L
Year: 2009
Journal: Immunity
Title: Interferon-gamma-responsive nonhematopoietic cells regulate the immune response to Mycobacterium tuberculosis.
Volume: 31
Issue: 6
Pages: 974-85
Publication
First Author: Pallotta MT
Year: 2011
Journal: Nat Immunol
Title: Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells.
Volume: 12
Issue: 9
Pages: 870-8
Publication  
First Author: Grunewald ME
Year: 2020
Journal: J Virol
Title: Murine Coronavirus Infection Activates the Aryl Hydrocarbon Receptor in an Indoleamine 2,3-Dioxygenase-Independent Manner, Contributing to Cytokine Modulation and Proviral TCDD-Inducible-PARP Expression.
Volume: 94
Issue: 3
Publication
First Author: Sharma MD
Year: 2015
Journal: Sci Adv
Title: The PTEN pathway in Tregs is a critical driver of the suppressive tumor microenvironment.
Volume: 1
Issue: 10
Pages: e1500845
Publication
First Author: Centuori SM
Year: 2012
Journal: J Leukoc Biol
Title: Myeloid-derived suppressor cells from tumor-bearing mice impair TGF-β-induced differentiation of CD4+CD25+FoxP3+ Tregs from CD4+CD25-FoxP3- T cells.
Volume: 92
Issue: 5
Pages: 987-97
Publication
First Author: McDermott JE
Year: 2016
Journal: BMC Syst Biol
Title: The effect of inhibition of PP1 and TNFα signaling on pathogenesis of SARS coronavirus.
Volume: 10
Issue: 1
Pages: 93
Publication  
First Author: Tousif S
Year: 2021
Journal: Front Immunol
Title: Indoleamine 2, 3-Dioxygenase Promotes Aryl Hydrocarbon Receptor-Dependent Differentiation Of Regulatory B Cells in Lung Cancer.
Volume: 12
Pages: 747780
Publication
First Author: Zhao F
Year: 2018
Journal: Immunity
Title: Paracrine Wnt5a-β-Catenin Signaling Triggers a Metabolic Program that Drives Dendritic Cell Tolerization.
Volume: 48
Issue: 1
Pages: 147-160.e7
Publication
First Author: Baban B
Year: 2009
Journal: J Immunol
Title: IDO activates regulatory T cells and blocks their conversion into Th17-like T cells.
Volume: 183
Issue: 4
Pages: 2475-83
Publication
First Author: Yun TJ
Year: 2016
Journal: Cell Metab
Title: Indoleamine 2,3-Dioxygenase-Expressing Aortic Plasmacytoid Dendritic Cells Protect against Atherosclerosis by Induction of Regulatory T Cells.
Volume: 23
Issue: 5
Pages: 852-66
Publication
First Author: Mackler AM
Year: 2003
Journal: J Immunol
Title: Indoleamine 2,3-dioxygenase is regulated by IFN-gamma in the mouse placenta during Listeria monocytogenes infection.
Volume: 170
Issue: 2
Pages: 823-30
Publication
First Author: Wong AC
Year: 2023
Journal: Cell
Title: Serotonin reduction in post-acute sequelae of viral infection.
Volume: 186
Issue: 22
Pages: 4851-4867.e20
Publication  
First Author: Li Q
Year: 2021
Journal: Front Immunol
Title: IL-10-/- Enhances DCs Immunity Against Chlamydia psittaci Infection via OX40L/NLRP3 and IDO/Treg Pathways.
Volume: 12
Pages: 645653
Publication
First Author: Lee SM
Year: 2017
Journal: Proc Natl Acad Sci U S A
Title: Inhibition of acute lethal pulmonary inflammation by the IDO-AhR pathway.
Volume: 114
Issue: 29
Pages: E5881-E5890
Publication  
First Author: Zengeler KE
Year: 2022
Journal: Brain Behav Immun
Title: SSRI treatment modifies the effects of maternal inflammation on in utero physiology and offspring neurobiology.
Volume: 108
Pages: 80-97
Publication      
First Author: Shanghai Model Organisms Center
Year: 2017
Journal: MGI Direct Data Submission
Title: Information obtained from the Shanghai Model Organisms Center (SMOC), Shanghai, China
Publication      
First Author: Mouse Genome Informatics and the Wellcome Trust Sanger Institute Mouse Genetics Project (MGP)
Year: 2011
Journal: Database Release
Title: Obtaining and Loading Phenotype Annotations from the Wellcome Trust Sanger Institute (WTSI) Mouse Resources Portal
Publication
First Author: Ingham NJ
Year: 2019
Journal: PLoS Biol
Title: Mouse screen reveals multiple new genes underlying mouse and human hearing loss.
Volume: 17
Issue: 4
Pages: e3000194
Publication
First Author: Visel A
Year: 2004
Journal: Nucleic Acids Res
Title: GenePaint.org: an atlas of gene expression patterns in the mouse embryo.
Volume: 32
Issue: Database issue
Pages: D552-6
Publication      
First Author: Wellcome Trust Sanger Institute
Year: 2010
Journal: MGI Direct Data Submission
Title: Alleles produced for the EUCOMM and EUCOMMTools projects by the Wellcome Trust Sanger Institute
Publication        
First Author: DDB, FB, MGI, GOA, ZFIN curators
Year: 2001
Title: Gene Ontology annotation through association of InterPro records with GO terms
Publication        
First Author: GOA curators
Year: 2016
Title: Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara
Publication        
First Author: UniProt-GOA
Year: 2012
Title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping, accompanied by conservative changes to GO terms applied by UniProt
Publication        
First Author: The Gene Ontology Consortium
Year: 2014
Title: Automated transfer of experimentally-verified manual GO annotation data to mouse-rat orthologs
Publication        
First Author: MGD Nomenclature Committee
Year: 1995
Title: Nomenclature Committee Use
Publication
First Author: Skarnes WC
Year: 2011
Journal: Nature
Title: A conditional knockout resource for the genome-wide study of mouse gene function.
Volume: 474
Issue: 7351
Pages: 337-42
Publication
First Author: Adams DJ
Year: 2024
Journal: Nature
Title: Genetic determinants of micronucleus formation in vivo.
Volume: 627
Issue: 8002
Pages: 130-136
Publication        
First Author: GemPharmatech
Year: 2020
Title: GemPharmatech Website.
Publication        
First Author: UniProt-GOA
Year: 2012
Title: Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping
Publication      
First Author: The Jackson Laboratory Mouse Radiation Hybrid Database
Year: 2004
Journal: Database Release
Title: Mouse T31 Radiation Hybrid Data Load
Publication        
First Author: The Gene Ontology Consortium
Year: 2010
Title: Automated transfer of experimentally-verified manual GO annotation data to mouse-human orthologs
Publication
First Author: Diez-Roux G
Year: 2011
Journal: PLoS Biol
Title: A high-resolution anatomical atlas of the transcriptome in the mouse embryo.
Volume: 9
Issue: 1
Pages: e1000582